Skip to main content

November's Most Popular Stories

Published: 11/29/22 2:07 pm
By Arvind Sommi

In case you missed them, below you’ll find our top four stories from November 2022. This month’s best stories cover a variety of topics including recipes, complications, a landmark FDA approval, and more!

1. Five Excellent Low-Carb Pasta Alternatives

If you like pasta but want low-carb recipes, these delicious options will allow you to hit your spaghetti spot without spiking your blood glucose.

2. Can You Have DKA Without High Blood Sugars?

Diabetic ketoacidosis (DKA) is a potentially fatal complication of diabetes typically associated with dangerously high blood glucose levels. However, this is not always the case, specifically for those who take a new class of diabetes drugs called SGLT-2 inhibitors.

3. FDA Approves Tzield (Teplizumab) to Delay Type 1 Diabetes

The FDA has approved Provention Bio’s Tzield (teplizumab), a new therapy that could delay the onset of type 1 diabetes by an average of 2 years. Find out about screening and how to know whether treatment with Tzield may be right for you.

4. How Ozempic Became a Celebrity Weight Loss Sensation

TikTok influencers are sharing how much weight they lost using Ozempic, an expensive type 2 diabetes drug, even if they do not have diabetes. This has led to a surge in demand among those willing to pay the high out-of-pocket cost – leading to a global shortage.

What do you think?

About the authors

Arvind Sommi joined the diaTribe Foundation in 2021 after graduating from the University of Florida with a degree in Biology. Sommi is an Editor for diaTribe Learn. Arvind Sommi joined... Read the full bio »